Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm
Sponsor: Ottawa Heart Institute Research Corporation
Summary
The objective of this study is to determine if there is a meaningful benefit to using the sedative medication dexmedetomidine in the acute treatment of patients with recurrent ventricular arrhythmias, known as electrical storm. This will be a multi-centre, double-blinded, placebo-controlled, randomized trial. Patients with electrical storm will be randomized to receive 48 to 72 hours of dexmedetomidine or placebo as part of their initial treatment in an intensive care unit.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
192
Start Date
2024-05-08
Completion Date
2027-08-01
Last Updated
2025-12-17
Healthy Volunteers
No
Conditions
Interventions
Dexmedetomidine
Dose range: 0.3 mcg/kg/hr to 1 mcg/kg/hr.
Normal saline
Programed as dexmedetomidine on infusion pump.
Locations (1)
University of Ottawa Heart Institute
Ottawa, Ontario, Canada